Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. Among authors: loke y. J Clin Epidemiol. 2023 Jun;158:149-165. doi: 10.1016/j.jclinepi.2023.04.005. Epub 2023 Apr 24. J Clin Epidemiol. 2023. PMID: 37100738 Free article.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. Among authors: loke y. BMJ. 2023 Apr 24;381:e073725. doi: 10.1136/bmj-2022-073725. BMJ. 2023. PMID: 37094878 Free article. Clinical Trial. No abstract available.
Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials.
Dehghani M, Sadeghi M, Barzkar F, Maghsoomi Z, Janani L, Motevalian SA, Loke YK, Ismail-Beigi F, Baradaran HR, Khamseh ME. Dehghani M, et al. Among authors: loke yk. Front Endocrinol (Lausanne). 2024 Mar 21;15:1286827. doi: 10.3389/fendo.2024.1286827. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38586456 Free PMC article.
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
Harris J, Pouwels KB, Johnson T, Sterne J, Pithara C, Mahadevan K, Reeves B, Benedetto U, Loke Y, Lasserson D, Doble B, Hopewell-Kelly N, Redwood S, Wordsworth S, Mumford A, Rogers C, Pufulete M. Harris J, et al. Among authors: loke y. Health Technol Assess. 2023 May;27(8):1-257. doi: 10.3310/MNJY9014. Health Technol Assess. 2023. PMID: 37435838 Free PMC article.
Patient-specific tissue engineered vascular graft for aortic arch reconstruction.
Hayashi H, Contento J, Matsushita H, Mass P, Cleveland V, Aslan S, Dave A, Santos RD, Zhu A, Reid E, Watanabe T, Lee N, Dunn T, Siddiqi U, Nurminsky K, Nguyen V, Kawaji K, Huddle J, Pocivavsek L, Johnson J, Fuge M, Loke YH, Krieger A, Olivieri L, Hibino N. Hayashi H, et al. Among authors: loke yh. JTCVS Open. 2024 Feb 27;18:209-220. doi: 10.1016/j.xjon.2024.02.012. eCollection 2024 Apr. JTCVS Open. 2024. PMID: 38690440 Free PMC article.
516 results